.
New Treatments for HIV,
Hepatitis, and Cancer

  

Raymond F. Schinazi

Founder and Director

Raymond F. Schinazi, PhD, DSc  is the Founder and Director of RFS Pharma, LLC.  He is also the Frances Winship Walters Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University. He serves as Senior Research Career Scientist at the Atlanta Department of Veterans Affairs and Director of the Scientific Working Group on Viral Eradication for the NIH-sponsored Emory University Center for AIDS Research (CFAR).  Dr. Schinazi received his BSc (1972) and PhD (1976) in chemistry from the University of Bath, England.  

 

He has authored over 500 peer-reviewed papers and 7 books and holds 92 issued U.S. patents and over 120 non-U.S. national stage patents and patent applications, which have resulted in 12 New Drug Applications (NDA). A world leader in nucleoside chemistry, Dr. Schinazi is best known for his pioneering work on HIV and HCV drugs d4T (stavudine), 3TC (lamivudine), FTC (emtricitabine/Emtriva), LdT (telbivudine), and most recently sofosbuvir (Sovaldi), which are now approved by the FDA.

 

More than 94% of HIV-infected individuals in the US on combination therapy take at least one of the drugs he invented, and it is estimated that his work has saved more than 3 million lives worldwide. His contributions related to HCV are expected to have a profound positive impact on the approximately 170 million people worldwide suffering from chronic infection.

 

Dr. Schinazi has been the recipient of numerous awards chronicling his track record of innovation and contributions to medical science including an honorary degree from Bath University, his Alma mater. Among these many awards, are the 2000 Bruce Witte Annual Distinguished Award from the Hepatitis B foundation. He served on the Presidential commission for AIDS during the Clinton administration. This year, Dr. Schinazi was awarded the Research and Hope Award for Excellence in Academic Research from the Pharmaceutical Research and Manufacturers of America (PhRMA) organization and the Distinguished Scientific Achievement Award from the American Liver Foundation, which was presented at the American Association for the Study of Liver Diseases Annual Conference in Boston. Furthermore, Dr. Schinazi has been awarded a Distinguished Lectureship from Emory University in recognition of his academic contributions.

For more information about Dr. Schinazi's achievements, visits our History of Success page.